This is a working overview of reversed-phase, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-22. Anything still debated is marked as such rather than presented as settled.
System suitability testing is performed before and during analytical runs to confirm that the instrument and method are working as expected. Common checks include retention time, peak area, resolution between critical pairs, tailing factor, and theoretical plate count. Results are compared with predefined limits, and a failed check requires investigation before sample results are reported. Quality control samples at low, middle, and high concentrations are injected at intervals to monitor accuracy and precision. Blank injections detect carryover and contamination, while control charts track performance over time.
Data handling and documentation are central to HPLC quality control. Electronic systems should have audit trails that record changes to methods, sequences, and results. Integration parameters, such as peak baseline and threshold, can affect reported areas and must be defined in advance. Out-of-specification results trigger a structured investigation that may include reanalysis, instrument checks, and review of sample preparation. Regulatory inspections often examine raw data, audit trails, and training records to verify that reported results are traceable and reliable.
Method validation establishes that an HPLC procedure is suitable for its intended use. Key parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Accuracy measures agreement with a true or accepted value, while precision describes repeatability and intermediate precision. Specificity confirms that the method measures the analyte without interference from impurities, degradants, or excipients. Validation is documented in a protocol and report, and acceptance criteria are set before experiments begin. Regulatory guidance varies by region, but the general principles are widely harmonized.
Quality control laboratories use HPLC to check identity, purity, concentration, and stability of raw materials and finished products. A validated method specifies the column, mobile phase, flow rate, detection wavelength, injection volume, and run time. Samples are prepared and compared against reference standards of known concentration. The resulting chromatogram provides quantitative data, such as assay values and impurity levels. This approach is common in pharmaceutical, food, environmental, and industrial testing where consistent measurements are required.
Method validation demonstrates that an analytical procedure is suitable for its intended purpose. Typical validation characteristics include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Regulatory guidance from bodies such as the International Council for Harmonisation and the United States Pharmacopeia outlines expectations, though specific criteria depend on the product and method. System suitability tests are run before sample analysis to confirm resolution, peak symmetry, column efficiency, and injection repeatability. Failure of these checks can invalidate a batch of measurements.
| Property | Value | Notes |
|---|---|---|
| Validation parameter | Accuracy | Measured value compared with true or accepted value |
| Precision type | Repeatability | Same analyst, instrument, and short time interval |
| Linearity range | 50–150% of target concentration | Common for assay methods; method-dependent |
| Limit of quantitation | Signal-to-noise ratio of 10:1 | Lowest concentration with acceptable precision |
| Common synonyms | Method validation, analytical validation | Documented confirmation that a method is suitable |
High-performance liquid chromatography testing separates components of a liquid sample by forcing a mobile phase through a packed column. The stationary phase inside the column interacts with analytes to different degrees, so each compound exits at a characteristic retention time. A pump delivers solvent at controlled flow and pressure, while an injector introduces a precise sample volume. Detectors such as ultraviolet-visible, fluorescence, refractive index, or mass spectrometric instruments record the separated bands. The resulting chromatogram provides qualitative and quantitative information about the mixture.
Separation modes differ by the chemistry of the stationary phase and the composition of the mobile phase. Reversed-phase testing uses a nonpolar column and polar solvents, making it common for pharmaceutical, environmental, and food analytes. Normal-phase testing uses a polar column and nonpolar solvents for compounds that are poorly retained in reversed-phase systems. Ion-exchange and ion-pair methods separate charged species, while size-exclusion methods sort molecules by hydrodynamic volume. Gradient elution changes solvent strength over time to resolve complex mixtures, and isocratic elution holds solvent composition constant for simpler assays.
Key performance measures include retention time, peak area, peak height, resolution, tailing factor, and plate count. Retention time helps identify a peak under fixed conditions, but confirmation often requires a second method or detector. Peak area and height relate to concentration through calibration curves, which may be linear or nonlinear depending on the detector response. Resolution describes separation between adjacent peaks, while tailing factor and plate count describe peak shape and column efficiency. Performance checks verify these values before and during a run to confirm that the instrument is performing within limits.
Several separation modes exist, including reversed-phase, normal-phase, ion-exchange, size-exclusion, and hydrophilic interaction liquid chromatography. Reversed-phase uses a nonpolar stationary phase with a polar mobile phase and is widely applied to small organic molecules. Gradient elution changes mobile phase composition during the run, while isocratic elution keeps it constant. Column chemistry, particle size, temperature, flow rate, and mobile phase pH all influence retention and resolution. Method development selects conditions that separate analytes from matrix components and from each other.
Detection commonly uses ultraviolet-visible absorbance, fluorescence, refractive index, or mass spectrometry. Ultraviolet detection depends on molecular chromophores that absorb light at specific wavelengths. Mass spectrometry provides mass information and sensitive quantification, often after electrospray ionization. Before sample batches, performance checks examine resolution, elution time repeatability, peak symmetry, and plate count. Matrix effects and co-elution remain recognized uncertainties; formal validation studies and orthogonal detection help address them. Detector choice depends on analyte properties and required sensitivity.
Separation performance depends on particle size, pore size, column length, and the chemistry of the stationary phase. Smaller particles generally improve efficiency but require higher pressure and suitable instrumentation. The mobile phase often contains buffers and organic solvents that influence retention and selectivity. Testing labs select conditions based on the analytes, sample matrix, and required sensitivity. Method development frequently involves screening several columns and solvent mixtures before a final set of conditions is chosen.
High-performance liquid chromatography is an analytical technique that separates components in a liquid sample by passing them through a packed column under pressure. A pump delivers a mobile phase at a controlled flow rate, and an injector introduces the sample into the stream. Differences in how analytes partition between the mobile phase and the stationary phase cause them to exit the column at different times. Detection then records a signal proportional to the amount of each separated substance. The resulting chromatogram provides retention times and peak areas for identification and quantification.
Instrumentation includes a solvent delivery system, an autosampler, a column oven, and one or more detectors. Reversed-phase columns with chemically modified silica are widely used, but normal-phase, ion-exchange, size-exclusion, and affinity modes exist for specific separations. Detectors may rely on ultraviolet absorbance, fluorescence, refractive index, or mass spectrometry. Column temperature, mobile phase composition, and flow rate are adjusted to improve resolution. System pressure is monitored because rising pressure can indicate column blockage or deteriorating packing.
Laboratories apply HPLC testing across pharmaceutical, food, environmental, and industrial chemistry. The method can measure active ingredients, impurities, additives, preservatives, and degradation products. Sample preparation often includes dilution, filtration, and sometimes extraction or derivatization. The choice of column, mobile phase, pH, temperature, and detector depends on the analytes and matrix. Results are compared with reference standards to assign identity and concentration. Method suitability is judged by resolution, precision, and accuracy.
HPLC testing is not a single fixed procedure; it is a family of separation modes. Reversed-phase, normal-phase, ion-exchange, size-exclusion, and affinity chromatography each suit different analyte properties. Reversed-phase methods dominate because they handle many neutral and moderately polar compounds. Detection can be optical, electrochemical, or mass spectrometric, and the detector dictates what information is available. Coupling with mass spectrometry increases selectivity and enables identification when standards are unavailable. The technique cannot separate every mixture without adjustment.
== Overdose == There is limited experience with overdose of suvorexant. Suvorexant has been assessed in single doses of as high as 240 mg in clinical studies. The medication dose-dependently produces somnolence. High doses of suvorexant may also cause sleep-onset paralysis in some individuals (2% incidence at doses of 40–240 mg). Treatment of suvorexant overdose is based on symptoms and is supportive. Gastric lavage may be used where appropriate whereas the value of dialysis has not been determined. Because suvorexant has high plasma protein binding, hemodialysis is not expected to enhance elimination of suvorexant.
After the end of World War II, Enewetak came under the control of the United States as part of the Trust Territory of the Pacific Islands, until the independence of the Marshall Islands in 1986. During its tenure, the United States evacuated the local residents many times, often involuntarily. The atoll was used for nuclear testing, as part of the Pacific Proving Grounds. Before testing commenced, the U.S. exhumed the bodies of United States servicemen killed in the Battle of Enewetak and returned them to the United States to be re-buried by their families. Forty-three nuclear tests were fired at Enewetak from 1948 to 1958. The first hydrogen bomb test, code-named Ivy Mike, occurred in late 1952 as part of Operation Ivy; it vaporized the islet of Elugelab and created two new elements: Fermium and Einsteinium. This test included B-17 Flying Fortress drones to fly through the radioactive cloud to test onboard samples. B-17 mother ships controlled the drones while flying within visual distance of them. In all, 16 to 20 B-17s took part in this operation, of which half were controlling aircraft and half were drones. To examine the explosion clouds of the nuclear bombs in 1957/58, several rockets (mostly from rockoons) were launched. One USAF airman, Jimmy Robinson, was lost at sea during the tests. Robinson's F-84 Thunderjet crashed and sank 3.5 miles (5.6 km) short of the island. Robinson's body was never recovered.
== History == The safety and efficacy of rusfertide were evaluated in the VERIFY trial, a multicenter, randomized, double-blind, placebo-controlled phase III study of 293 adults with polycythemia vera who required frequent phlebotomies despite ongoing standard-of-care therapy. Participants were randomized 1:1 to receive either rusfertide or placebo over 32 weeks. Mimrylo treatment started at 19 mg, administered subcutaneously (under the skin) once weekly, and was titrated to maintain hematocrit levels below 45%. Efficacy was measured by the proportion of participants who did not meet criteria for phlebotomy between weeks 20 and 32 of the study. Overall, 76.9% of participants on rusfertide required no phlebotomies during the 32-week period compared to 32.9% on placebo.
Sources: en.wikipedia.org
== Further reading == Williams, John, ed. (1861). The physicians of Myddvai; Meddygon Myddfai (or the medical practice of the celebrated Rhiwallon and his sons, of Myddvai, in Caermarthenshire, physicians to Rhys Gryg, Lord of Dynevor and Ystrad Towy, about the middle of the thirteenth century). Translated by Pughe, John. Llandovery. From ancient Mss. in the libraries of Jesus College, Oxford, Llanover, and Tonn; with an English translation; and the legend of the Lady of Llyn y Van.
In 1920, Hermann Staudinger published his seminal work "Über Polymerisation", in which he proposed that polymers were in fact long chains of atoms linked by covalent bonds. His work was debated at length, but eventually it was accepted by the scientific community. Because of this work, Staudinger was awarded the Nobel Prize in 1953. After the 1930s polymers entered a golden age during which new types were discovered and quickly given commercial applications, replacing naturally-sourced materials. This development was fuelled by an industrial sector with a strong economic drive and it was supported by a broad academic community that contributed innovative syntheses of monomers from cheaper raw material, more efficient polymerisation processes, improved techniques for polymer characterisation and advanced, theoretical understanding of polymers.
== Bioencapsulations == Alginate is one of the most widely used polymers in bioencapsulation, particularly for the immobilisation or protection of living cells, enzymes, proteins and other bioactive materials. Its use is largely based on the ability of soluble alginate to form calcium alginate hydrogels under mild aqueous conditions, allowing biological material to be entrapped without exposure to harsh solvents, high temperature or aggressive chemical reactions. In cell encapsulation, alginate beads or microcapsules can provide a semipermeable hydrogel matrix that permits diffusion of nutrients, oxygen and secreted products while physically separating the encapsulated cells from the surrounding environment. This approach has been investigated for immunoisolation, islet transplantation, cell therapy, tissue engineering and controlled delivery of biological products. Alginate bioencapsulation systems can be produced by dripping, extrusion, air-jet cutting, electrostatic droplet generation, emulsification and microfluidic methods. These techniques differ in throughput, bead-size control, size distribution and suitability for encapsulating cells or labile biomolecules.
Sources: en.wikipedia.org
=== Available forms === Dutasteride was originally provided in the form of soft, oil-filled gelatin capsules containing 0.5mg dutasteride each. In India, manufacturers variously formulate tablets and soft and hard capsules of 0.5mg while many versions come combined with tamsulosin, alfuzosin or silodosin. A 0.1mg capsule is also available in Japan.
== Discovery == The first observation of a moonlighting protein was made in the late 1980s by Joram Piatigorsky and Graeme Wistow during their research on crystallin enzymes. Piatigorsky determined that lens crystallin conservation and variance are due to other moonlighting functions outside of the lens. Originally Piatigorsky called these proteins "gene sharing" proteins, but the colloquial description moonlighting was subsequently applied to proteins by Constance Jeffery in 1999 to draw a similarity between multitasking proteins and people who work two jobs. The phrase "gene sharing" is ambiguous since it is also used to describe horizontal gene transfer, hence the phrase "protein moonlighting" has become the preferred description for proteins with more than one function.
Lack of sufficient insulin (but enough to prevent ketosis) Poor kidney function Poor fluid intake (dehydration) Older age (50–70 years) Certain medical conditions (cerebral vascular injury, myocardial infarction, sepsis) Certain medications (glucocorticoids, beta-blockers, thiazide diuretics, calcium channel blockers, and phenytoin)
Seven months later the paratroopers of the 82nd Airborne Division were again called to war. Four days after the Iraqi invasion of Kuwait on 2 August 1990, the 4th Battalion (Airborne), 325th Infantry was the Division Ready Force 1 (DRF-1) and the initial ground force invaded Iraq on the orders of President George Bush Sr. after his "Line in the sand" speech to Saddam Hussein part of the largest deployment of American troops since Vietnam as part of "Operation Desert Shield." The 4–325th INF immediately deployed to Riyadh and Thummim, Saudi Arabia. Their role was to guard the royal family as part of the agreement with King Fahd to station troops in and around the kingdom. The DRF 2 and 3 (1–325 and 2-325 INF, respectively) began drawing the "line in the sand" near al Jubail by building defenses for possible retrograde operations. Soon after, the rest of the division followed. There, intensive intelligence operations began in anticipation of desert fighting against the heavily armored Iraqi Army. On 16 January 1991, Operation Desert Storm began when American war planes attacked Iraqi targets. As the air war began, 2nd Brigade of the 82nd initially deployed near an airfield in the vicinity of the Saudi Aramco oil facilities outside Abqaiq, Saudi Arabia. While 1st Brigade and 3d Brigade consolidated at the Division HQ (CHAMPION Main) near Dhahran in Coinciding with the start of the air war, three National Guard Light-Medium Truck companies, the 253d (NJARNG), 1122d (AKARNG), and the 1058th (MAARNG) joined 2d Brigade of the 82nd.
Sources: en.wikipedia.org
System suitability is a set of checks that confirm the instrument and method perform within limits before sample analysis. It typically includes resolution, tailing factor, retention time, and peak area reproducibility. If a check fails, the run is invalidated until the cause is resolved.
QC samples are usually injected at the beginning, at intervals during the run, and at the end. The exact frequency depends on the method, sample count, and regulatory requirements. Results outside acceptance limits can require rejection of the affected samples and investigation.
Method validation demonstrates that an HPLC procedure produces reliable results for its intended purpose. It provides documented evidence for accuracy, precision, specificity, and other performance characteristics. Regulators and quality systems require validation before a method is used for release or stability testing.
Method validation is the documented process of confirming that an HPLC procedure is suitable for its intended use. It evaluates accuracy, precision, specificity, linearity, range, detection limits, and robustness. Validation criteria depend on the regulatory context and the sample type.